Drugs / Influvac TetraTM
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04192500 Comparator | Dec 2019 → Sep 2020 | influenza | Osivax | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influvac TetraTM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04192500 ↗ |
| Modality | Vaccine | “Influvac TetraTM, quadrivalent seasonal influenza sub-unit vaccine” NCT04192500 ↗ |
| Route | Intramuscular | “One single administration intramuscularly at Day 1.” NCT04192500 ↗ |